Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 2.84 USD -1.39% Market Closed
Market Cap: $268.5m

During the last 3 months Compugen Ltd insiders have not bought any shares, and sold 99.2k USD worth of shares. The stock price has increased by 33% over this period (open performance analysis).

The last transaction was made on Apr 14, 2026 by Ophir Eran , who sold 14.5k USD worth of CGEN shares.

Last Transactions:
Ophir Eran
$-14.5k
Levine Zurit
$-5.6k
Levine Zurit
$-8k
Levine Zurit
VP, Human Resources
$-8k
Levine Zurit
$-13k
Levine Zurit
VP, Human Resources
$-5.8k
Levine Zurit
$-7.7k
Ophir Eran
$-12.4k
Levine Zurit
$-24.2k
View All Transactions

During the last 3 months Compugen Ltd insiders have not bought any shares, and sold 99.2k USD worth of shares. The stock price has increased by 33% over this period (open performance analysis).

The last transaction was made on Apr 14, 2026 by Ophir Eran , who sold 14.5k USD worth of CGEN shares.

Sold
0-3
months
99.2k USD
2
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Compugen Ltd
Insider Trading Chart

Compugen Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Compugen Ltd
Last Insider Transactions

Global
Insiders Monitor

Compugen Ltd
Glance View

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. The firm focuses on infrastructure to discover drug targets and develop therapeutics. The firm is engaged in the research, development and commercialization of therapeutic and product candidates. The firm's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

CGEN Intrinsic Value
3.76 USD
Undervaluation 24%
Intrinsic Value
Price $2.84

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett